Giuseppe Derosa Selected Research

Type 2 Diabetes Mellitus (MODY)

03/2008	Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
01/2008	Effects of Manidipine/Delapril versus Olmesartan/Hydrochlorothiazide Combination Therapy in Elderly Hypertensive Patients with Type 2 Diabetes Mellitus.
04/2007	Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
05/2006	Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
05/2005	Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
10/2004	Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
07/2003	A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus.
05/2003	The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus.
02/2003	Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors.

Articles by Research Topic

Disease

9	Type 2 Diabetes Mellitus (MODY) 03/2008 - 02/2003
6	Hypertension (High Blood Pressure) 09/2007 - 07/2003
6	Syndrome 05/2006 - 05/2004
3	Insulin Resistance 05/2008 - 09/2004
2	Atrial Fibrillation 09/2008 - 03/2008
2	Overweight 05/2008 - 08/2007
1	Acute Coronary Syndrome 07/2007
1	Inflammation 10/2006
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2005
1	Hyperlipidemias (Hyperlipidemia) 10/2004
1	Coronary Disease (Coronary Heart Disease) 10/2004
1	Obesity 08/2004
1	Hypercholesterolemia 04/2003

Drug/Important Bio-Agent (IBA)

7	rosiglitazone (Avandia)FDA Link 05/2008 - 05/2004
7	glimepiride (Amarel)FDA LinkGeneric 05/2006 - 02/2003
4	Amlodipine (Norvasc)FDA LinkGeneric 03/2008 - 09/2004
3	Metformin (Glucophage)FDA LinkGeneric 05/2008 - 05/2005
3	irbesartan FDA LinkGeneric 04/2007 - 06/2005
3	pioglitazone (Actos)FDA Link 05/2006 - 05/2004
2	valsartan (Vals)FDA Link 09/2008 - 03/2008
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2008 - 09/2007
2	atorvastatin (Lipitor)FDA Link 10/2006 - 09/2004
2	Lipoprotein(a)IBA 05/2006 - 05/2003
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2006 - 11/2005
2	Doxazosin (Cardura)FDA LinkGeneric 04/2006 - 06/2005
2	fluvastatin FDA Link 10/2004 - 04/2003
1	Ramipril (Altace)FDA LinkGeneric 09/2008
1	Atenolol (Tenormin)FDA LinkGeneric 03/2008
1	delaprilIBA 01/2008
1	manidipineIBA 01/2008
1	olmesartanIBA 01/2008
1	candesartan cilexetil (Amias)FDA Link 09/2007
1	Psyllium (Metamucil)IBA 08/2007
1	Metalloproteases (Metalloproteinases)IBA 07/2007
1	moxonidine (Moxon)IBA 04/2007
1	LeptinIBA 11/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2006
1	telmisartan (Micardis)FDA Link 11/2006
1	Insulin (Novolin)FDA Link 10/2006
1	Tissue Inhibitor of Metalloproteinase-1IBA 05/2006
1	HomocysteineIBA 05/2006
1	C-Reactive ProteinIBA 04/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2006
1	2,4-thiazolidinedione (thiazolidinedione)IBA 11/2005
1	Procetofen (CiL)FDA LinkGeneric 10/2004
1	Protein Isoforms (Isoforms)IBA 08/2004
1	Apoprotein(a) (Apolipoprotein (a))IBA 08/2004
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2003
1	candesartanIBA 07/2003
1	Perindopril FDA Link 07/2003
1	Nifedipine (Adalat)FDA LinkGeneric 07/2003
1	lercanidipineIBA 07/2003
1	Carnitine (L-Carnitine)FDA LinkGeneric 05/2003
1	orlistat (Xenical)FDA Link 04/2003
1	repaglinide (Prandin)FDA Link 02/2003